Veeva Systems, a provider of cloud software for the life sciences industry, unveiled Vault CRM, its next generation of CRM for life sciences. Built on the Veeva Vault Platform, Vault CRM has the full functionality of Veeva CRM and significant new innovations including two new applications: CRM Bot and Service Center.

Integrated into Vault CRM, CRM Bot is an intelligent assistant designed to help sales and medical teams be more productive. The AI application leverages customer-specific CRM activity data combined with Veeva Link and Veeva Compass data in a private customer instance. Service Center is an integrated call center application for inside sales and hybrid reps. Service Center is included in Vault CRM at no additional charge and CRM Bot is a separately licensed product integrated with Vault CRM.

“We are excited to deliver the next generation of CRM for life sciences,” said Veeva CEO Peter Gassner. “Vault CRM represents the most innovation ever from Veeva with an AI-powered CRM Bot, integrated call center, and the full functionality of Veeva CRM. With significant advances in CRM and the work we’ve done to modernize patient and prescriber data, Veeva Commercial Cloud provides the industry with a solution built for today’s complex treatments and engagement models.”

All Veeva CLM and Veeva CRM approved email content will work seamlessly with Vault CRM and Vault CRM uses the same mobile and desktop applications as Veeva CRM.

The first Vault CRM customers are expected to be live in 2024. The first migrations from Veeva CRM to Vault CRM are expected in 2025 and most companies will migrate in the 2026 to 2029 timeframe. Veeva also announced an expanded business partnership with Accenture to help customers optimize their processes and leverage new innovations as part of their migration to Vault CRM.

Veeva recently announced the addition of Veeva Compass Prescriber and Compass National data products which will join Compass Patient to create a suite of modern data products to power commercial analytics and operations for today’s complex therapies.